US-based Nipro Medical has announced the launch of its Elisio Polynephron dialyser, designed for the renal market, targeting those involved in care and procedures for kidney disease and dialysis.

The Elisio dialyser is equipped with a new high-flux membrane, Polynephron. According to Nipro Medical, the Polynephron membrane functions similarly to a human kidney and delivers biocompatibility, haemocompatibility, and solute-removal performance.

A 3D chemical structure enables a mixture of hydrophilic and hydrophobic domains, while reducing membrane fouling and maximising membrane performance.

Advanced pore-spinning technology of the new dialysis device creates more homogenous pore sizes to optimise sieving properties.

“A 3D chemical structure enables a mixture of hydrophilic and hydrophobic domains, while reducing membrane fouling and maximising membrane performance.”

Ripple structure of Elisio’s fibre creates less dialysate channelling, promoting improved diffusive transportation while enhancing small molecule clearances, and reducing the risk of fibre leakage.

The inner design of the Elisio dialyser offers a smooth polyurethane cut surface, which helps minimise the risk of blood cell damage.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

An improved header shape reduces channelling at the blood side, and the redesigned permanent caps eliminate the possibility of unexpected removal or reuse.

Nipro North America senior vice-president Joe Dawson said: “The introduction of the Elisio dialyser builds on our strategy of becoming a complete and cost-effective dialysis solutions leader, offering blood tubing lines, fistulas needles, and now dialysers to our dialysis market partners in the US market. Elisio is designed to deliver an elevated benefits platform to the market, especially in clearance performance of small to middle molecules, and it delivers on these objectives.

“Both in-vitro and in-vivo testing have demonstrated the superior clearance performance of the Elisio dialyser for both small and middle molecules. In addition, clinicians reported excellent performance with regard to myglobin and B2 microglobulin, and excellent biocompatibility on WBC and C5a.

Nipro Medical has already obtained 510(k) approval from the US Food and Drug Administration for the Elisio Polynephron dialyser.

The single use, high-flux, hollow-fibre dialyser is now available in sizes from 90H to 250H.